|
Device to help heart failure patients earns second place in annual Engineering …
Your Houston News HOUSTON (May 7, 2014) – A team of Texas A&M University bio-medical engineering students, mentored and advised by Texas Heart Institute (THI) Director of Electrophysiology Clinical Research Mehdi Razavi, MD, took second place in the University’s … |
Research and Markets: Chronic Heart Failure – Pipeline Review, H1 2014: 22 …Business Wire (press release)This report provides comprehensive information on the therapeutic development for Chronic Heart Failure, complete with comparative analysis at va…
Fundraiser in the City for man fighting congestive heart failureRoyal GazetteSo reads the plea for donations from the Bermuda Heart Foundation for Garry Dill, a local father of four suffering from congestive heart failure in desperate need of a heart t…
|
Acetaminophen in Rx drugs: For liver’s sake, lower the dose, says FDA
Los Angeles Times Your liver will thank you — acetaminophen overdose has overtaken viral hepatitis infection as the most common cause of acute liver failure. It is now the second most common cause of liver failure requiring transplantation in the United States … |
Recently Released Market Study: Chronic Kidney Disease Partnering 2009-2014DigitalJournal.comBoston, MA — (SBWIRE) — 05/06/2014 — The Chronic Kidney Disease Partnering 2009-2014 provides understanding and access to the chronic kidney disease partner…
MedscapeWelltok Launches Pilot with Aetna To Help Members with Chronic Kidney DiseaseHIT ConsultantWelltok, Aetna and the National Kidney Foundation recently launched a 12 month pilot program that aims to help Aetna members with Chronic Kidney Disease …
Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Review, H1 2014DigitalJournal.comThis report provides comprehensive information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with comparative ana…
Acute Heart Failure – Pipeline Review, H1 2014DigitalJournal.comThis report provides comprehensive information on the therapeutic development for Acute Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug…
MedscapeAetna Works with National Kidney Foundation, Welltok to Help Members with …MarketWatchAetna (NYSE: AET ), the National Kidney Foundation and Welltok recently launched a pilot program that aims to help Aetna members with Chronic Kidney Disease…
|
REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart …
TCTMD Eplerenone, a mineralocorticoid receptor antagonist, is typically used for the treatment of chronic heart failure (HF). For the study, Gilles Montalescot, MD, PhD, of the Centre Hospitalier Pitié-Salpêtrière (Paris, France), and colleagues randomized 1 … CardioNotes: STEMI Tx, Kids’ Cholesterol, Bystander CPRMedPage Today |